These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
227 related articles for article (PubMed ID: 20496770)
1. [Clinical significance of measurement of free light chains]. Matsuda M Rinsho Byori; 2010 Apr; 58(4):401-4. PubMed ID: 20496770 [TBL] [Abstract][Full Text] [Related]
2. Clinical usefulness of free light chain concentration as a tumor marker in multiple myeloma. Kang SY; Suh JT; Lee HJ; Yoon HJ; Lee WI Ann Hematol; 2005 Sep; 84(9):588-93. PubMed ID: 15883850 [TBL] [Abstract][Full Text] [Related]
3. The evolving use of serum free light chain assays in haematology. Pratt G Br J Haematol; 2008 May; 141(4):413-22. PubMed ID: 18318757 [TBL] [Abstract][Full Text] [Related]
4. Serum free light chain measurement aids the diagnosis of myeloma in patients with severe renal failure. Hutchison CA; Plant T; Drayson M; Cockwell P; Kountouri M; Basnayake K; Harding S; Bradwell AR; Mead G BMC Nephrol; 2008 Sep; 9():11. PubMed ID: 18808676 [TBL] [Abstract][Full Text] [Related]
5. [Clinical usefulness of serum free light chain measurement in monoclonal gammopathy]. Shimazaki C; Murakami H; Sawamura M; Matsuda M; Kinoshita T; Hata H; Sugiura I; Tsushita K; Nagura E; Kosugi H; Itoh J; Shimizu K Rinsho Ketsueki; 2010 Apr; 51(4):245-52. PubMed ID: 20467220 [TBL] [Abstract][Full Text] [Related]
6. Quantitative analysis of serum free light chains. A new marker for the diagnostic evaluation of primary systemic amyloidosis. Abraham RS; Katzmann JA; Clark RJ; Bradwell AR; Kyle RA; Gertz MA Am J Clin Pathol; 2003 Feb; 119(2):274-8. PubMed ID: 12579999 [TBL] [Abstract][Full Text] [Related]
7. [Determination of light chains in serum]. Hansen CT; Nielsen L; Münster AM; Abildgaard N Ugeskr Laeger; 2010 Aug; 172(34):2302-5. PubMed ID: 20727297 [TBL] [Abstract][Full Text] [Related]
8. [Evaluation of the clinical relevance of serum measurements of free-light chains in patients with multiple myeloma]. Shimizu K; Itoh J; Sugiura I; Tsushita K; Kosugi H; Nagura E Rinsho Ketsueki; 2006 Apr; 47(4):303-9. PubMed ID: 16715965 [TBL] [Abstract][Full Text] [Related]
9. Use of interval-specific likelihood ratios improves clinical interpretation of serum FLC results for the diagnosis of malignant plasma cell disorders. Vermeersch P; Vercammen M; Holvoet A; Vande Broek I; Delforge M; Bossuyt X Clin Chim Acta; 2009 Dec; 410(1-2):54-8. PubMed ID: 19778527 [TBL] [Abstract][Full Text] [Related]
10. Proposed reference material for human free immunoglobulin light chain measurement. Nakano T; Miyazaki S; Shinoda Y; Inoue I; Katayama S; Komoda T; Nagata A J Immunoassay Immunochem; 2006; 27(2):129-37. PubMed ID: 16711251 [TBL] [Abstract][Full Text] [Related]
11. Comparison of Free Light Chain Assays: Freelite and N Latex in Diagnosis, Monitoring, and Predicting Survival in Light Chain Amyloidosis. Mahmood S; Wassef NL; Salter SJ; Sachchithanantham S; Lane T; Foard D; Whelan CJ; Lachmann HJ; Gillmore JD; Hawkins PN; Wechalekar AD Am J Clin Pathol; 2016 Jul; 146(1):78-85. PubMed ID: 27353767 [TBL] [Abstract][Full Text] [Related]
12. Correlations among different markers determined by immunochemical methods used for the diagnosis and monitoring of intact immunoglobulin multiple myeloma cases. Dogaru M; Lazăr V; Coriu D Roum Arch Microbiol Immunol; 2012; 71(4):183-200. PubMed ID: 23755700 [TBL] [Abstract][Full Text] [Related]
13. Assessing the efficiency of free light chain assay in monitoring patients with multiple myeloma before and after autologous stem cell transplantation along with serum protein electrophoresis and serum protein immunofixation. Dogaru M; Lazăr V; Coriu D Roum Arch Microbiol Immunol; 2011; 70(1):15-22. PubMed ID: 21717807 [TBL] [Abstract][Full Text] [Related]
14. Serum levels of free light chain before and after chemotherapy in primary systemic AL amyloidosis. Matsuda M; Yamada T; Gono T; Shimojima Y; Ishii W; Fushimi T; Sakashita K; Koike K; Ikeda S Intern Med; 2005 May; 44(5):428-33. PubMed ID: 15942088 [TBL] [Abstract][Full Text] [Related]
15. Diagnostic performance of serum free light chain measurement in patients suspected of a monoclonal B-cell disorder. Vermeersch P; Van Hoovels L; Delforge M; Mariën G; Bossuyt X Br J Haematol; 2008 Nov; 143(4):496-502. PubMed ID: 18729849 [TBL] [Abstract][Full Text] [Related]